cornelius_merlini_metamark

Metamark names new chief commercial officer

January 31, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cornelius, metamark

US Biotech firm Metamark Genetics has named the former general manager of HealthTronics Laboratory Solutions Cornelius Merlini, as its senior …

Lilly image

Lilly to go ‘on offense’

January 31, 2014
Sales and Marketing Alimta, Lechleiter, cymbalta, lilly, q4, zyprexa

The loss of patent on antidepressant Cymbalta in the US last December was largely responsible for Eli Lilly & Co’s …

Roche image

Oncology drives Roche profits

January 30, 2014
Sales and Marketing Actemra, Perjeta, Roche, Swiss, q4

Sales at Roche’s pharma division rose 7% year-on-year in 2013, driven largely by strong performances from its oncology portfolio. Group …

Stem cell breakthrough heralded by scientists

January 30, 2014
Research and Development, Sales and Marketing BBC, regenerative medicine, stap, stem cell

Researchers have discovered a simple method of producing mice stem cells that could mark a new era of regenerative medicine.  …

screen_shot_2014-02-04_at_14

Novo Nordisk appoints chief medical officer

January 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, todd hobbs

Dr Todd Hobbs has been appointed chief medical officer (CMO) for Novo Nordisk in North America.   In this role …

Sales rise for Novartis

January 30, 2014
Sales and Marketing Gleevec, Glivec, Novartis, gilenya, q4, sales

Multiple sclerosis drug Gilenya, with sales rising 62% year-on-year to $1.9 billion, was one of the stars of last year …

GSK vaccines

GSK halts chickenpox vaccines over quality concerns

January 29, 2014
Manufacturing and Production, Sales and Marketing Boostrix-Polio, GSK, Varilrix, chickenpox, vaccines

GlaxoSmithKline has suspended worldwide distribution of two chickenpox vaccines after production standards were not met at one of its facilities …

Pfizer image

Profits drop for Pfizer

January 29, 2014
Sales and Marketing Enbrel, Lipitor, Pfizer, Spiriva, Zoetis, q4

Pfizer’s turnover fell to $54.6 billion in 2013, a 6% drop year-on-year from $54.7 billion in 2012, but the group …

screen_shot_2014-01-29_at_10

High-dose Copaxone the right medicine for Teva

January 29, 2014
Research and Development, Sales and Marketing Biogen, Copaxone, FDA, MS, Mylan, Teva

The FDA has approved a high-dose version of Teva’s multiple sclerosis drug Copaxone which will help the firm offset approaching …

matthias_zachert_merck

Merck KGaA head jumping ship to Lanxess

January 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, Merck KGaA, lanxess, zachert

Merck KGaA’s chief financial officer Matthias Zachert is exiting the firm in order to fulfill a chief executive appointment at …

servier image

Servier signs cancer partnership

January 29, 2014
Research and Development, Sales and Marketing AbbVie, Servier, breast cancer, curie

Servier has extended by three years its deal with leading research group Curie-Cancer to identify therapeutic targets for treating triple-negative …

Pfizer image

Pfizer lung cancer drug suffers late-stage setback

January 28, 2014
Research and Development, Sales and Marketing Cancer, NSCLC, Pfizer, Roche, Tarceva, dacomitinib

An experimental cancer drug developed by Pfizer has failed in two separate Phase III clinical studies. Dacomitinib is a tyrosine …

UCB image

UCB launches online challenge to find new drugs

January 28, 2014
Medical Communications UCB, crowdsourcing, innovation challenge, website

UCB has launched its ‘Innovation Challenge’ as it looks to pay members of the public to help develop new drugs. …

NICE looks at Xtandi again

January 28, 2014
Sales and Marketing Astellas, NHS, NICE, Xtandi

NICE has announced it is to consult again on its decision to recommend Astellas Pharma’s prostate cancer drug Xtandi after …

john_p

Targacept appoints chairman

January 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept, richard

Clinical-stage biopharma firm Targecept has appointed its non-executive director since 2002 John Richard to be its chairman of the board. …

doh image

NICE rejects ‘benefit’ test

January 28, 2014
Sales and Marketing Dillon, EMIG, NHS, NICE, benefits

NICE has refused to include a ‘wider societal benefit’ test into its deliberations about which drugs should be available on …

J&J: we’re proud to top social media leaderboard

January 27, 2014
Medical Communications, Sales and Marketing IMS, J&J, JJ, Janssen, digital, epatient, pharma

Johnson & Johnson says recognising the rise of the ePatient and being willing to share its corporate plans with the …

BMS image

BMS revenue drops in 2013

January 27, 2014
Sales and Marketing AZ, BMS, Yervoy, diabetes, hep C, q4

Bristol-Myers’ Squibb’s revenue has fallen 7% year-on-year to $16.4 billion during 2013. Turnover rose 6% to $4.4 billion in the …

The Gateway to Local Adoption Series

Latest content